Italia markets closed

Dow Jones
37.944,59
-516,33(-1,34%)
Nasdaq
15.498,39
-214,36(-1,36%)
Nikkei 225
37.628,48
-831,60(-2,16%)
EUR/USD
1,0720
+0,0020(+0,18%)
Bitcoin EUR
59.704,84
-596,06(-0,99%)
CMC Crypto 200
1.389,07
+6,49(+0,47%)

RTX Corporation (0R2N.L)

LSE - LSE Prezzo differito. Valuta in USD.

Aggiungi a watchlist

94,92

+0,56

(+0,59%)

Alla chiusura: 06:11PM BST

Capitalizzazione	812,257M
Beta (5 anni mensile)	0,60
Rapporto PE (ttm)	0,34
EPS (ttm)	2,79
Prossima data utili	23 lug 2024 - 29 lug 2024
Rendimento e dividendo (futuro)	N/D (N/D)
Data ex dividendo	N/D
Stima target 1A	N/D

Tutte

GlobeNewswire
Predictive Oncology Appoints Dr. Bernard A. Harris, Jr. to its Newly Formed Business Advisory Board
EAGAN, Minn., June 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and enable drug development, today announced the appointment of Dr. Bernard A. Harris, Jr. to its newly-formed